Xingruo Zeng

Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19

Yingjie Wu, Xiaoxing Huang, Jiaxing Sun et al. · mSphere · 2020 · 113 citations · Full text

Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 Axis

Guosong Jiang, Amy D. Wu, Chao Huang et al. · Cancer Prevention Research · 2016 · 67 citations · Full text

Tumor Biology, Urology, Oncology +15

PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure

Haishan Huang, Xiaofu Pan, Honglei Jin et al. · Clinical Cancer Research · 2015 · 64 citations · Full text

MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1

Xu Zhou, Xingruo Zeng, Daofeng Tian et al. · Biochemical and Biophysical Research Communications · 2014 · 47 citations

Cell Regulation, Glioma, Medicine +9

Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both<i>In Vitro</i>and<i>In Vivo</i>

Xingruo Zeng, Xu Zhou, Jiayan Gu et al. · Molecular Cancer Therapeutics · 2016 · 46 citations · Full text

Engineering, Tumor Biology, Transcriptional Regulation +18